Author:
Beckford Vera Denis R.,Eigner Sebastian,Eigner Henke Katerina,Leyva Montaña Rene,Melichar Frantisek,Beran Milos
Publisher
Springer Berlin Heidelberg
Reference57 articles.
1. Almqvist Y, Steffen AC, Tolmachev V, Divgi CR, Sundin A (2006) In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer. Nucl Med Biol 33(8):991–998
2. Beckford Vera DR, Eigner S, Beran M, Henke KE, Laznickova A, Laznicek M et al (2011) Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm 26(3):287–297
3. Beckford Vera DR, Eigner S, Henke KE, Lebeda O, Melichar F, Beran M (2011) Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. Nucl Med Biol 39(1):3–13
4. Beckford Vera DR, Xiques Castillo A, Leyva Montaña R, Pérez Malo M, Gonzalez Casanova E, Zamora Barrabi M (2007) New radioimmunoconjugate 90Y-DOTA-h-R3. Synthesis and radiolabeling. Nucleus 41:3–8
5. Blend MJ, Stastny JJ, Swanson SM, Brechbiel MW (2003) Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent. Cancer Biother Radiopharm 18(3):355–363
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献